Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5‐Year Update

Authors

William S. Tierney, Vanderbilt University, Nashville, TN
Li-Ching Huang, Vanderbilt University, Nashville, TN
Sheau-Chiann Chen, Vanderbilt University, Nashville, TN
Lynn D. Berry, Vanderbilt University, Nashville, TN
Catherine Anderson, Vanderbilt University, Nashville, TN
Milan R. Armin, University of Wisconsin, Madison, WI
Michael S. Benninger, New York University, New York, NY
Joel H. Blumin, Cleveland Clinic, Cleveland, OH
Jonathan M. Bock, Cleveland Clinic, Cleveland, OH
Paul C. Bryson, New York University, New York, NY
Paul F. Castellanos, Medical College of Wisconsin, Milwaukee, WI
Matthew S. Clary, Mercy Health–St. Rita's Ear, Nose and Throat, Lima, OH
Seth M. Cohen, University of Colorado, Denver, CO
Brianna K. Crawley, Duke University, Durham, NC
Seth H. Dailey, Loma Linda University Health, Loma Linda, CA
James J. Daniero, University of Virginia, Charlottesville, VA
Alessandro de Alarcon, University of Cincinnati, Cincinnati, OH
Donald T. Donovan, Baylor University, Houston, TX
Eric S. Edell, Mayo Clinic, Rochester, MN
Dale C. Ekbom, Mayo Clinic, Rochester, MN
Daniel S. Fink, Mercy Health–St. Rita's Ear, Nose and Throat, Lima, OH
Ramon A. Franco, Harvard University, Boston, MA
Catherine Gaelyn Garrett, Vanderbilt University , Nashville, TN
Elizabeth A. Guardiani, University of Maryland, Baltimore, MD
Alexander T. Hillel, Johns Hopkins University, Baltimore, MD
Henry T. Hoffman, University of Iowa, Iowa City, IA
Norman D. Hogikyan, University of Michigan, Ann Arbor, MI
Rebecca J. Howell, University of Cincinnati, Cincinnati, OH
Andrew McWhorter, LSU Health Sciences Center - New OrleansFollow
et al.

Document Type

Article

Publication Date

1-19-2023

Publication Title

Otolaryngology–Head and Neck Surgery

Abstract

The North American Airway Collaborative (NoAAC) previously published a 3-year multi-institutional prospective cohort study showing variation in treatment effectiveness between 3 primary surgical techniques for idiopathic subglottic stenosis (iSGS). In this report, we update these findings to include 5 years of data evaluating treatment effectiveness. Patients in the NoAAC cohort were re-enrolled for 2 additional years and followed using the prespecified published protocol. Consistent with prior data, prospective observation of 487 iSGS patients for 5 years showed treatment effectiveness differed by modality. Cricotracheal resection maintained the lowest rate of recurrent operation (5%), followed by endoscopic resection with adjuvant medical therapy (30%) and endoscopic dilation (50%). These data support the initial observations and continue to provide value to providers and patients navigating longitudinal decision-making. Level of evidence: 2—prospective cohort study.

First Page

1570

Last Page

1575

Issue

6

Publisher

Wiley

Comments

See article for full Author List

Rights

©2022 The American Laryngological, Rhinological and Otological Society, Inc ©1999-2025 John Wiley & Sons, Inc

Recommended Citation

Tierney, William S.; Huang, Li-Ching; Chen, Sheau-Chiann; Berry, Lynn D.; Anderson, Catherine; Armin, Milan R.; Benninger, Michael S.; Blumin, Joel H.; Bock, Jonathan M.; Bryson, Paul C.; Castellanos, Paul F.; Clary, Matthew S.; Cohen, Seth M.; Crawley, Brianna K.; Dailey, Seth H.; Daniero, James J.; de Alarcon, Alessandro; Donovan, Donald T.; Edell, Eric S.; Ekbom, Dale C.; Fink, Daniel S.; Franco, Ramon A.; Garrett, Catherine Gaelyn; Guardiani, Elizabeth A.; Hillel, Alexander T.; Hoffman, Henry T.; Hogikyan, Norman D.; Howell, Rebecca J.; McWhorter, Andrew; and al., et, "Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5‐Year Update" (2023). School of Graduate Studies Faculty Publications. 490.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/490
10.1002/ohn.190